Page last updated: 2024-08-24

tenofovir and Asymptomatic Conditions

tenofovir has been researched along with Asymptomatic Conditions in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Furquim d'Almeida, A; Ho, E; Van Hees, S; Vanwolleghem, T1
Alagaratnam, J; Boffito, M; Bozzali, M; Cercignani, M; Mora-Peris, B; Nelson, M; Toniolo, S; Underwood, J; Vera, JH; Winston, A1
Benko, E; Blazkova, J; Casazza, JP; Chun, TW; Costiniuk, CT; Fauci, AS; Hallahan, CW; Kandel, G; Kaul, R; Kim, CJ; Koup, RA; Kovacs, C; Moir, S; Murray, D; Ostrowski, M; Shawn Justement, J1
Alcantarini, C; Bonora, S; Calcagno, A; Cusato, J; D'Avolio, A; Di Perri, G; Lucchiari, M; Marinaro, L; Mengozzi, G; Simiele, M; Tettoni, MC; Trentini, L1

Reviews

1 review(s) available for tenofovir and Asymptomatic Conditions

ArticleYear
Clinical management of chronic hepatitis B: A concise overview.
    United European gastroenterology journal, 2022, Volume: 10, Issue:1

    Topics: Aged; Antiviral Agents; Asymptomatic Diseases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Esophageal and Gastric Varices; Hepatic Encephalopathy; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Liver Neoplasms; Male; Seroconversion; Tenofovir; Withholding Treatment

2022

Other Studies

3 other study(ies) available for tenofovir and Asymptomatic Conditions

ArticleYear
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
    Journal of neurovirology, 2020, Volume: 26, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asymptomatic Diseases; Benzoxazines; Cognitive Dysfunction; Connectome; Cyclopropanes; Drug Substitution; Emtricitabine; Executive Function; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxazines; Piperazines; Prospective Studies; Pyridones; Raltegravir Potassium; Rilpivirine; Tenofovir

2020
Effect of antiretroviral therapy on HIV reservoirs in elite controllers.
    The Journal of infectious diseases, 2013, Nov-01, Volume: 208, Issue:9

    Topics: Adenine; Anti-HIV Agents; Asymptomatic Diseases; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV-1; Humans; Immunity, Innate; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Viremia; Virus Replication

2013
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment.
    AIDS (London, England), 2016, Mar-27, Volume: 30, Issue:6

    Topics: Adult; Anti-HIV Agents; Asymptomatic Diseases; Cross-Sectional Studies; Female; HIV Infections; Humans; Kidney Function Tests; Male; Middle Aged; Plasma; Renal Insufficiency; Tenofovir; Urine

2016